Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FT557
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $96,871
Award facts
- Contract value 100% obligated
- $96,871.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $96,871.16 by the Defense Logistics Agency (DLA) on November 3, 2025, with an ultimate completion date of November 4, 2025. The award is for Enbrel 50 mg/mL SureClick auto-injector units and represents a firm fixed-price, competitively awarded contract with no set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally.
The award supports the Defense Health Agency and other federal military healthcare systems by providing critical pharmaceutical commodities. Enbrel is a biologic medication used to treat autoimmune conditions and is regularly procured through DLA medical supply channels. AmerisourceBergen's status as a prime vendor under the SPE2DX contract reflects its capability to meet federal procurement requirements through open competition and its role as a key provider in the military's pharmaceutical supply chain. The firm fixed-price delivery order structure ensures cost certainty for this specific pharmaceutical transaction.
Quick answers
Who was awarded contract SPE2DR26FT557?
SPE2DR26FT557 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FT557 worth?
The government has obligated $96,871 on SPE2DR26FT557.
Is contract SPE2DR26FT557 an order under another contract?
Yes. SPE2DR26FT557 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT557 competed?
The extent of competition for SPE2DR26FT557 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award